Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Adult Clinical Oral Nutrition Market
Adult Clinical Oral Nutrition Market size crossed USD 8 billion in 2022 and is poised to depict over 5% CAGR through 2023-2032, on account of the growing burden of chronic diseases.
With the mounting prevalence of non-communicable diseases such as malnutrition and obesity, the rate of prolonged hospitalization is increasing globally. Based on study data from Baxter International, approximately 2 million hospital stays involve malnutrition in the U.S. Such factors will boost the acceptance of oral nutritional therapy as a safe and effective way to fight adult malnutrition. Likewise, the burden of chronic and metabolic disorders has risen across the globe, further increasing demand for the therapy.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Adult Clinical Oral Nutrition Market Size in 2022: | USD 8 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 5% |
2032 Value Projection: | USD 13 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 280 |
Tables, Charts & Figures: | 387 |
Segments covered: | Product, Therapeutic Area, Form, Sales Channel, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Additionally, according to the International Diabetes Federation, in 2021, over 537 million adults were diagnosed with diabetes in middle- and low-income countries. The requirement for malnutrition management among hospitalized patients with diabetes will therefore surge and in turn, strengthen the industry outlook. However, the introduction of stringent regulatory frameworks associated with product efficacy and labeling may restrict the development of adult oral nutrition support solutions to some extent over the forecast period.